Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma

Circulating tumor DNA (ctDNA) is assumed to reflect tumor burden and has been suggested as a tool for prognostication and follow‐up in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC). However, the prognostic value of ctDNA and its relation with tumor burden has yet to be substantia...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cancer Vol. 146; no. 5; pp. 1445 - 1456
Main Authors: Strijker, Marin, Soer, Eline C., Pastena, Matteo, Creemers, Aafke, Balduzzi, Alberto, Beagan, Jamie J., Busch, Olivier R., Delden, Otto M., Halfwerk, Hans, Hooft, Jeanin E., Lienden, Krijn P., Marchegiani, Giovanni, Meijer, Sybren L., Noesel, Carel J., Reinten, Roy J., Roos, Eva, Schokker, Sandor, Verheij, Joanne, Vijver, Marc J., Waasdorp, Cynthia, Wilmink, Johanna W., Ylstra, Bauke, Besselink, Marc G., Bijlsma, Maarten F., Dijk, Frederike, Laarhoven, Hanneke W.
Format: Journal Article
Language:English
Published: Hoboken, USA John Wiley & Sons, Inc 01.03.2020
Wiley Subscription Services, Inc
Subjects:
ISSN:0020-7136, 1097-0215, 1097-0215
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first